explore -WSS

explore

author：hotspot 2025-09-27 22:59:50 - browse：28454

Powdered ibogaine against a white background. — Tabernanthe iboga, the shrub that contains the psychedelic substance ibogaine. Wikimedia Commons

The psychedelic ibogaine is unlikely to ever receive approval as a treatment for opioid addiction, the federal government’s top addiction researcher said Thursday.

The remarks from Nora Volkow, the longtime director of the National Institute on Drug Abuse, serve as a cautionary note amid widespread enthusiasm about ibogaine, a naturally occurring substance that drug companies and researchers have increasingly cast as a potential paradigm-shifting addiction treatment.

But its potential cardiac side effects could stand in the way of receiving approval from the Food and Drug Administration, Volkow said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Brain 'hot spot' may explain why African Americans feel greater pain

WSS

Connecting traumatic brain injury and domestic violence

Meta looks to target Twitter with a rival app called Threads

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

5 important ways Henrietta Lacks changed medical science

No plane should take off without an EpiPen onboard

focus

explore

entertainment

Guidelines to prevent youth baseball injuries need more muscle

5 important ways Henrietta Lacks changed medical science

Malaria cases in Florida and Texas: Here’s what you need to know

7 people shot in DC, police say

The cancer drug shortage isn’t new — and neither are the solutions

7 people shot in DC, police say

What does generative AI mean for health care? We asked experts

These geoengineering technologies could help combat the climate crisis, scientists say

New air purifier tech could be key to improving indoor air quality

4th of July breaks record for highest global temperature ever measured

explore

The high personal cost of affirmative action for Black doctors

Community addresses injustice for Long Island mothers

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

New case study details death in closely watched Alzhiemer's trial

Doctor appointment wait times are getting worse

What the US credit downgrade means for the economy, your finances

hotspot

knowledge

focus

explore